2-[4-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]phenyl]acetamide;2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)phenyl]acetic acid;2-[4-[7-amino-6-(4-fluorophenyl)-3-naphthalen-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]cyclohexyl]acetic acid;2-[4-(7-amino-3-naphthalen-2-yl-6-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]acetic acid;ethyl 5-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-2-carboxylate
C120H110Br3FN26O9 — CID 159427255
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]phenyl]acetamide;2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)phenyl]acetic acid;2-[4-[7-amino-6-(4-fluorophenyl)-3-naphthalen-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]cyclohexyl]acetic acid;2-[4-(7-amino-3-naphthalen-2-yl-6-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]acetic acid;ethyl 5-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-2-carboxylate
2-[4-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]phenyl]acetamide;2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)phenyl]acetic acid;2-[4-[7-amino-6-(4-fluorophenyl)-3-naphthalen-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]cyclohexyl]acetic acid;2-[4-(7-amino-3-naphthalen-2-yl-6-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]acetic acid;ethyl 5-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-2-carboxylate (PubChem CID 159427255) has the molecular formula C120H110Br3FN26O9 and a molecular weight of 2319.08 g/mol. Its IUPAC name is 2-[4-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]phenyl]acetamide;2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)phenyl]acetic acid;2-[4-[7-amino-6-(4-fluorophenyl)-3-naphthalen-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]cyclohexyl]acetic acid;2-[4-(7-amino-3-naphthalen-2-yl-6-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]acetic acid;ethyl 5-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-2-carboxylate.
Molecular Properties
| Compound Name | 2-[4-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]phenyl]acetamide;2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)phenyl]acetic acid;2-[4-[7-amino-6-(4-fluorophenyl)-3-naphthalen-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]cyclohexyl]acetic acid;2-[4-(7-amino-3-naphthalen-2-yl-6-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]acetic acid;ethyl 5-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-2-carboxylate |
|---|---|
| PubChem CID | 159427255 |
| Molecular Formula | C120H110Br3FN26O9 |
| Molecular Weight | 2319.08 g/mol |
| Exact Mass | 2314.65 |
| IUPAC Name | 2-[4-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]phenyl]acetamide;2-[4-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)phenyl]acetic acid;2-[4-[7-amino-6-(4-fluorophenyl)-3-naphthalen-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]cyclohexyl]acetic acid;2-[4-(7-amino-3-naphthalen-2-yl-6-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-5-yl)cyclohexyl]acetic acid;ethyl 5-[7-amino-6-bromo-3-(1-methylpyrrol-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl]piperidine-2-carboxylate |
| SMILES | CCOC(=O)C1CCC(c2nc3c(-c4ccn(C)c4)cnn3c(N)c2Br)CN1.Cn1ccc(-c2cnn3c(N)c(Br)c(-c4ccc(CC(N)=O)cc4)nc23)c1.Nc1c(-c2ccc(F)cc2)c(C2CCC(CC(=O)O)CC2)nc2c(-c3ccc4ccccc4c3)cnn12.Nc1c(-c2ccncc2)c(C2CCC(CC(=O)O)CC2)nc2c(-c3ccc4ccccc4c3)cnn12.Nc1c(Br)c(-c2ccc(CC(=O)O)cc2)nc2c(-c3cnc4ccccc4c3)cnn12 |
| InChI | InChI=1S/C30H27FN4O2.C29H27N5O2.C23H16BrN5O2.C19H23BrN6O2.C19H17BrN6O/c31-24-13-11-20(12-14-24)27-28(21-7-5-18(6-8-21)15-26(36)37)34-30-25(17-33-35(30)29(27)32)23-10-9-19-3-1-2-4-22(19)16-23;30-28-26(20-11-13-31-14-12-20)27(21-7-5-18(6-8-21)15-25(35)36)33-29-24(17-32-34(28)29)23-10-9-19-3-1-2-4-22(19)16-23;24-20-21(14-7-5-13(6-8-14)9-19(30)31)28-23-17(12-27-29(23)22(20)25)16-10-15-3-1-2-4-18(15)26-11-16;1-3-28-19(27)14-5-4-11(8-22-14)16-15(20)17(21)26-18(24-16)13(9-23-26)12-6-7-25(2)10-12;1-25-7-6-13(10-25)14-9-23-26-18(22)16(20)17(24-19(14)26)12-4-2-11(3-5-12)8-15(21)27/h1-4,9-14,16-18,21H,5-8,15,32H2,(H,36,37);1-4,9-14,16-18,21H,5-8,15,30H2,(H,35,36);1-8,10-12H,9,25H2,(H,30,31);6-7,9-11,14,22H,3-5,8,21H2,1-2H3;2-7,9-10H,8,22H2,1H3,(H2,21,27) |
| InChIKey | LQNFXKVNDKROKA-UHFFFAOYSA-N |
| XLogP | 22.46 |
| TPSA | 510.01 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 159 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2319.08 |
| LogP ≤ 5 | 22.46 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 31 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159427255 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.